BioMarin Pharmaceutical Inc.BMRNNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-100.00%
↓ 1142% below average
Average (9y)
-8.05%
Historical baseline
Range
High:14.96%
Low:-100.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | -100.00% |
| 2024 | 0.06% |
| 2023 | 14.96% |
| 2022 | 3.31% |
| 2021 | 0.11% |
| 2020 | -12.15% |
| 2019 | 2.68% |
| 2018 | 14.01% |
| 2017 | -7.73% |
| 2016 | 4.27% |